Matinas BioPharma
MTNB
49 hedge funds and large institutions have $13M invested in Matinas BioPharma in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 23 increasing their positions, 9 reducing their positions, and 6 closing their positions.
156% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 9
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
2% more funds holding
Funds holding: 48 → 49 (+1)
0.01% less ownership
Funds ownership: 0.25% → 0.24% (-0.01%)
14% less capital invested
Capital invested by funds: $15.1M → $13M (-$2.09M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
+$171K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$161K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$124K |
| 4 |
BlackRock
New York
|
+$108K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$95.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IA
IFP Advisors
Tampa,
Florida
|
-$577K |
| 2 |
AWMG
Alliance Wealth Management Group
Flemington,
New Jersey
|
-$515K |
| 3 |
AA
ALPS Advisors
Denver,
Colorado
|
-$120K |
| 4 |
State Street
Boston,
Massachusetts
|
-$61.1K |
| 5 |
IIA
IPG Investment Advisors
San Diego,
California
|
-$58.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
IIA
51
IPG Investment Advisors
San Diego,
California
| – | -$58.7K | -890 | Closed |
|
52
Creative Planning
Overland Park,
Kansas
| – | -$49K | -745 | Closed |
|
|
JMPWA
53
JP Morgan Private Wealth Advisors
San Francisco,
California
| – | -$40K | -600 | Closed |
|
|
NFA
54
Nationwide Fund Advisors
Columbus,
Ohio
| – | -$39K | -597 | Closed |
|
|
SO
55
STRS Ohio
Columbus,
Ohio
| – | -$20K | -308 | Closed |
|
MTNB Hedge Fund Activity: Q4 2017 in Review
49 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Matinas BioPharma (MTNB) for Q4 2017, worth a combined $13M — down 14% from $15.1M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new MTNB positions and 6 closed out — a net gain of 1 holder — while 23 added to existing stakes and 9 trimmed.
The largest buyer was American Century Companies, opening a new position worth an estimated $171K. The largest seller was IFP Advisors, cutting an estimated $577K.
- 49 institutional investors held Matinas BioPharma (MTNB) as of Q4 2017, up from 48 in Q3 2017.
- Funds reported $13M of Matinas BioPharma stock for Q4 2017, down 14% quarter-over-quarter.
- 7 funds opened new Matinas BioPharma positions in Q4 2017 and 6 closed out, a net change of +1 holder.
- The largest Matinas BioPharma buyer in Q4 2017 was American Century Companies, an estimated $171K added.
- The largest Matinas BioPharma seller in Q4 2017 was IFP Advisors, an estimated $577K sold.
Based on aggregated 13F filings for Q4 2017.